8-K - PALVELLA THERAPEUTICS, INC. - 5.02
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193125-26-151979
Filing Date: 2026-04-13
Accepted: 2026-04-13 07:30:08
Documents: 9
Period of Report: 2026-04-13
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
PALVELLA THERAPEUTICS, INC. (Filer) CIK : 0001583648 (see all company filings) EIN. : 300784346 | State of Incorp.: NV | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 26856438 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | pvla-20260413.htm iXBRL | 8-K
2 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | pvla-20260413.xsd | EX-101.SCH
12 | EXTRACTED XBRL INSTANCE DOCUMENT | pvla-20260413_htm.xml | XML